|
US3009864A
(en)
|
1958-09-18 |
1961-11-21 |
Union Carbide Corp |
Process control
|
|
US3228838A
(en)
|
1959-04-23 |
1966-01-11 |
Union Carbide Corp |
Preservation of biological substances
|
|
US3009861A
(en)
|
1961-01-13 |
1961-11-21 |
Alderton Gordon |
Isolation of bacterial spores
|
|
US3608030A
(en)
|
1969-05-21 |
1971-09-21 |
Howard Tint |
Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
|
|
US4077227A
(en)
|
1976-11-12 |
1978-03-07 |
Regents Of The University Of Minnesota |
Method of freezing liquid material in which agglomeration is inhibited
|
|
US4205132A
(en)
|
1978-07-17 |
1980-05-27 |
Microlife Technics, Inc. |
Lyophilization of bacteria
|
|
FI59925C
(fi)
|
1980-01-11 |
1981-11-10 |
Esko Viljo Nurmi |
Foerfarande foer framstaellning av ett bakteriepreparat anvaendbart foer foerhindrande av salmonellainfektion hos fjaederfae
|
|
US4655047A
(en)
|
1985-03-25 |
1987-04-07 |
I.Q.F. Inc. |
Process for freezing or chilling
|
|
US4839281A
(en)
|
1985-04-17 |
1989-06-13 |
New England Medical Center Hospitals, Inc. |
Lactobacillus strains and methods of selection
|
|
EP0439453B1
(en)
|
1987-10-12 |
1994-01-19 |
Exomed Australia Pty. Ltd. (ACN 051 976 446) |
Improved method for treatment of gastrointestinal disorders
|
|
US5045446A
(en)
|
1988-08-26 |
1991-09-03 |
Cryopharm Corporation |
Lyophilization of cells
|
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
|
ATE165738T1
(de)
|
1988-08-02 |
1998-05-15 |
Gastro Services Pty Ltd |
Behandlung von gastro-intestinalen krankheiten
|
|
GB2233343B
(en)
|
1989-06-30 |
1993-07-07 |
Farmos Oy |
A bacterial preparation for use in poultry
|
|
JP2961182B2
(ja)
|
1990-03-09 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
JP2961184B2
(ja)
|
1990-05-07 |
1999-10-12 |
ミヤリサン株式会社 |
クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物
|
|
US5436002A
(en)
|
1991-01-29 |
1995-07-25 |
Mycogen Corporation |
Bacillus thuringiensisisolate PS201T6 toxin
|
|
RU2035186C1
(ru)
|
1992-07-09 |
1995-05-20 |
Семен Рафаилович Резник |
Профилактический биопрепарат споролакт
|
|
WO1994008598A1
(en)
|
1992-10-09 |
1994-04-28 |
Advanced Tissue Sciences, Inc. |
Liver reserve cells
|
|
US5599795A
(en)
|
1994-08-19 |
1997-02-04 |
Mccann; Michael |
Method for treatment of idiopathic inflammatory bowel disease (IIBD)
|
|
WO1997008598A1
(de)
|
1995-08-25 |
1997-03-06 |
Gff Technopark |
Verfahren zur simultanen, digitalen phasenempfindlichen detektion von zeitaufgelösten, quasi-gleichzeitig erfassten datenarrays eines periodisch stimulierten systems
|
|
DE69635496T2
(de)
|
1995-09-15 |
2006-07-27 |
Gerding, Dale N., Chicago |
Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
|
|
AUPO430496A0
(en)
|
1996-12-19 |
1997-01-23 |
Arnott's Biscuits Limited |
Prebiotics and probiotics
|
|
US5965128A
(en)
|
1997-08-13 |
1999-10-12 |
University Of Georgia Research Foundation Inc. |
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
|
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
US6589771B1
(en)
|
1999-10-28 |
2003-07-08 |
Immunom Technologies, Inc. |
Methods for arousing dormant bacteria
|
|
US20030118547A1
(en)
|
2000-01-27 |
2003-06-26 |
Vandenberg Grant William |
Composition for intestinal delivery
|
|
AU2001233529A1
(en)
|
2000-02-10 |
2001-08-20 |
Andrew W. Bruce |
Probiotic therapy for newborns
|
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
AU2100402A
(en)
|
2000-11-30 |
2002-06-11 |
Bio Balance Corp |
Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
|
|
AU2002353763B2
(en)
|
2001-05-04 |
2007-01-04 |
University Of Florida Research Foundation, Inc |
Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
|
|
ITMI20011632A1
(it)
|
2001-07-27 |
2003-01-27 |
Sanofi Synthelabo |
Composizione solida contenente spore di batteri non patogeni del genere bacillus
|
|
GB0130789D0
(en)
|
2001-12-21 |
2002-02-06 |
King S College London |
Application of spores
|
|
US8383342B2
(en)
|
2002-04-24 |
2013-02-26 |
The University Of North Carolina At Greensboro |
Compositions, products, methods and systems to monitor water and other ecosystems
|
|
GB0212975D0
(en)
|
2002-06-06 |
2002-07-17 |
Mars Uk Ltd |
Mammalian animal composition
|
|
AU2002951692A0
(en)
|
2002-09-23 |
2002-10-17 |
Vital Biotech (Hong Kong) Limited |
Improvements in or relating to vaccines
|
|
WO2004069156A2
(en)
*
|
2003-01-30 |
2004-08-19 |
The Regents Of The University Of California |
Inactivated probiotic bacteria and methods of use thereof
|
|
US8617870B2
(en)
|
2003-03-13 |
2013-12-31 |
University Of Ottawa |
Antioxidant producing bacterium and uses thereof
|
|
CA2522957C
(en)
|
2003-04-23 |
2013-10-22 |
Medarex, Inc. |
Compositions and methods for the therapy of inflammatory bowel disease
|
|
EP1473370A3
(en)
|
2003-04-24 |
2005-03-09 |
BioMerieux, Inc. |
Genus, group, species and/or strain specific 16S rDNA Sequences
|
|
WO2004104175A2
(en)
|
2003-05-14 |
2004-12-02 |
University Of Georgia Research Foundation, Inc. |
Probiotic bacteria and methods
|
|
CA2535892A1
(en)
|
2003-08-18 |
2005-02-24 |
The Bio Balance Corporation |
A stable liquid probiotic composition, preparation and applications thereof
|
|
US20050048515A1
(en)
|
2003-08-29 |
2005-03-03 |
Garner Bryan E. |
Methods for detecting and quantifying specific probiotic microorganisms in animal feed
|
|
US7731976B2
(en)
|
2003-08-29 |
2010-06-08 |
Cobb And Company, Llp |
Treatment of irritable bowel syndrome using probiotic composition
|
|
US20050239706A1
(en)
|
2003-10-31 |
2005-10-27 |
Washington University In St. Louis |
Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
ES2531971T3
(es)
|
2004-02-03 |
2015-03-23 |
Prevtec Microbia Inc. |
Uso de bacterias vivas para fomentar el crecimiento en animales
|
|
US7632520B2
(en)
|
2004-02-16 |
2009-12-15 |
Sanjeev Khandelwal |
Synergistic antibacterial formulation and to a method of making the same
|
|
US7854927B2
(en)
|
2004-05-11 |
2010-12-21 |
Ganeden Biotech, Inc. |
Methods and compositions for the dietary management of autoimmune disorders
|
|
ES2523316T3
(es)
|
2004-11-01 |
2014-11-24 |
Erber Aktiengesellschaft |
Bacteriófagos como agentes selectivos
|
|
US20090197249A1
(en)
|
2004-11-01 |
2009-08-06 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
US20060188523A1
(en)
|
2005-01-10 |
2006-08-24 |
Zhiheng Pei |
Methods for diagnosing and treating chronic tonsillitis
|
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
ES2607988T3
(es)
|
2005-05-31 |
2017-04-05 |
Iams Europe B.V. |
Bifidobacterias probióticas felinas
|
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
|
EP1931363B1
(en)
|
2005-09-28 |
2015-11-18 |
Nordisk Rebalance A/S |
Treatment of ibd using both probiotic bacteria and fermented cereal as treatment effectors
|
|
US8968721B2
(en)
|
2005-12-28 |
2015-03-03 |
Advanced Bionutrition Corporation |
Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
|
|
WO2007136553A2
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Bacterial strains, compositions including same and probiotic use thereof
|
|
JP5019563B2
(ja)
|
2006-06-16 |
2012-09-05 |
旭化成ケミカルズ株式会社 |
腸内細菌賦活剤
|
|
RU2009101475A
(ru)
|
2006-06-20 |
2010-07-27 |
Конинклейке Филипс Электроникс, Н.В. (Nl) |
Электронная капсула и способ для лечения желудочно-кишечного заболевания
|
|
TW200819540A
(en)
|
2006-07-11 |
2008-05-01 |
Genelux Corp |
Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
|
|
EE05459B1
(et)
|
2006-12-08 |
2011-08-15 |
Tartu �likool |
Sporogeense Bacillus smithii tvi TBMI12 MSCL P737 ja selle endospooride kasutamine probiootikumina, toidulisandina ning probiootiline kompositsioon
|
|
WO2008076696A2
(en)
|
2006-12-18 |
2008-06-26 |
Washington University In St. Louis |
The gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder
|
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
|
WO2008083157A2
(en)
|
2006-12-29 |
2008-07-10 |
Washington University In St. Louis |
Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
|
|
EA017564B1
(ru)
|
2007-09-12 |
2013-01-30 |
Тарганта Терапьютикс Корп. |
Способ ингибирования клостридиум диффициле введением оритаванцина
|
|
US8236508B2
(en)
|
2008-01-29 |
2012-08-07 |
Drexel University |
Detecting and measuring live pathogens utilizing a mass detection device
|
|
US8021654B2
(en)
|
2008-03-14 |
2011-09-20 |
Danisco A/S |
Methods of treating pigs with Bacillus strains
|
|
RU2010144789A
(ru)
|
2008-04-01 |
2012-05-10 |
Метаметрикс Клиникал Лэборетери (Us) |
Процесс и способ мониторинга желудочно-кишечной микрофлоры
|
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
|
JP2011528117A
(ja)
|
2008-07-15 |
2011-11-10 |
メタノミクス ヘルス ゲーエムベーハー |
胃バイパス及びそれに関連する状態を診断する手段及び方法
|
|
CN102131928A
(zh)
|
2008-08-26 |
2011-07-20 |
奥林巴斯株式会社 |
粪便试样的调制方法、粪便试样调制用溶液、及粪便采集用试剂盒
|
|
WO2010030997A1
(en)
|
2008-09-12 |
2010-03-18 |
The Washington University |
Regulating intestinal microbiota dependent signaling as a means to modulate body fat and/or weight loss
|
|
EP2337569A4
(en)
|
2008-09-25 |
2013-04-03 |
Univ New York |
COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING THE STOMACH DARM, SKIN AND NOSE MICROBIOTA
|
|
JP5620392B2
(ja)
|
2008-11-03 |
2014-11-05 |
タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ |
クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
IT1393931B1
(it)
|
2009-02-25 |
2012-05-17 |
Neuroscienze Pharmaness S C A R L |
Composizione di spore di batteri non patogeni
|
|
EP2432484A1
(en)
|
2009-04-30 |
2012-03-28 |
Compagnie Gervais Danone |
Use of collinsella aerofaciens for reducing bloating
|
|
CN102481322A
(zh)
|
2009-05-01 |
2012-05-30 |
微制药有限公司 |
预防和治疗退化性疾病的细菌组合物
|
|
US9050276B2
(en)
|
2009-06-16 |
2015-06-09 |
The Trustees Of Columbia University In The City Of New York |
Autism-associated biomarkers and uses thereof
|
|
WO2011046614A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods and systems for phylogenetic analysis
|
|
EP2446062B1
(en)
|
2009-06-26 |
2014-08-13 |
The Regents of the University of California |
Methods and systems for phylogenetic analysis
|
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
|
IN2012DN00878A
(es)
|
2009-08-18 |
2015-05-22 |
Nestec Sa |
|
|
WO2011022542A2
(en)
|
2009-08-19 |
2011-02-24 |
Puretech Ventures, Llc |
Administration of factors normally present in a microbial niche to improve health
|
|
US20120149584A1
(en)
|
2009-08-21 |
2012-06-14 |
Bernat Olle |
Methods of diagnosing and treating microbiome-associated disease using interaction network parameters
|
|
GB0916335D0
(en)
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
ES2660008T3
(es)
|
2009-09-23 |
2018-03-20 |
Thomas Julius Borody |
Terapia para infecciones entéricas crónicas
|
|
US20120238468A1
(en)
|
2009-10-05 |
2012-09-20 |
Aak Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
|
US20110081320A1
(en)
|
2009-10-06 |
2011-04-07 |
Nubiome, Inc. |
Treatment/Cure of Autoimmune Disease
|
|
WO2011046616A2
(en)
|
2009-10-15 |
2011-04-21 |
New York University |
Methods for modulating bacterial infection
|
|
PH12012500687A1
(en)
|
2009-11-12 |
2012-10-29 |
Nestec Sa |
Nutritional composition for promoting gut microbiota balance and health
|
|
MX348611B
(es)
|
2009-12-31 |
2017-06-21 |
Milton Trachtman Ira |
Forma de dosificación oral para usarse en el tratamiento de enfermedad inflamatoria de intestino debido a una infección bacteriana.
|
|
US9492487B2
(en)
|
2010-02-01 |
2016-11-15 |
Matthew Ryan Garner |
Microbial product containing multiple microorganisms
|
|
RS63299B1
(sr)
|
2010-02-01 |
2022-07-29 |
Rebiotix Inc |
Bakterioterapija clostridium difficile kolitisa
|
|
WO2011103123A2
(en)
|
2010-02-16 |
2011-08-25 |
Arizona Technology Enterprises |
Reducing short-chain fatty acids and energy uptake in obese humans by managing their intestinal microbial communities
|
|
CN102939391A
(zh)
|
2010-03-01 |
2013-02-20 |
国家农艺研究院 |
炎症性肠病的诊断方法
|
|
CA2791464A1
(en)
|
2010-03-01 |
2011-09-09 |
Institut National De La Recherche Agronomique |
Method of diagnosis of obesity
|
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
|
WO2011113801A1
(en)
|
2010-03-16 |
2011-09-22 |
Universiteit Gent |
Use of clostridium perfringens strain 23 to protect against necrotic enteritis
|
|
US8951512B2
(en)
|
2010-05-04 |
2015-02-10 |
New York University |
Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
JP5940064B2
(ja)
|
2010-07-06 |
2016-06-29 |
ノバルティス アーゲー |
低用量のｒｎａを用いた大型哺乳動物の免疫化
|
|
WO2012009712A2
(en)
|
2010-07-16 |
2012-01-19 |
The Board Of Trustees Of The University Of Arkansas |
Methods and compositions including spore-forming bacteria for increasing the health of animals
|
|
FI20105825A7
(fi)
|
2010-07-26 |
2012-01-27 |
Suomen Punainen Risti Veripalvelu |
Veriryhmästatuksen käyttö III
|
|
NZ607043A
(en)
|
2010-08-04 |
2015-05-29 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
WO2012033814A2
(en)
|
2010-09-10 |
2012-03-15 |
Viropharma Incorporated |
Environmental clostridial bacteriotherapy and related formulations and methods of manufacture and use
|
|
CA2813080A1
(en)
|
2010-10-04 |
2012-04-12 |
British Columbia Cancer Agency Branch |
Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer
|
|
EP2637650A2
(en)
|
2010-11-10 |
2013-09-18 |
National Jewish Health |
Methods to test allergic conditions
|
|
US20120064592A1
(en)
|
2011-01-26 |
2012-03-15 |
Qteros, Inc. |
Biocatalysts synthesizing deregulated cellulases
|
|
JP5905032B2
(ja)
|
2011-02-09 |
2016-04-20 |
ラヴィヴォ・アーベー |
腸管内微生物叢の回復および再構成のためのシンバイオティクス組成物
|
|
WO2012116289A2
(en)
|
2011-02-25 |
2012-08-30 |
Tricorder Diagnostics, Llc |
Microbial signatures as indicators of radiation exposure
|
|
WO2012122522A2
(en)
|
2011-03-09 |
2012-09-13 |
Washington University |
Cultured collection of gut microbial community
|
|
CA2829385C
(en)
|
2011-03-09 |
2021-07-13 |
Michael J. Sadowsky |
Compositions and methods for transplantation of colon microbiota
|
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
|
US20120276056A1
(en)
|
2011-04-26 |
2012-11-01 |
Wieslaw Janusz Bochenek |
Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
|
|
WO2012159023A2
(en)
|
2011-05-19 |
2012-11-22 |
Virginia Commonwealth University |
Gut microflora as biomarkers for the prognosis of cirrhosis and brain dysfunction
|
|
US9579353B2
(en)
|
2011-06-10 |
2017-02-28 |
Prothera, Inc. |
Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
|
|
WO2013008102A2
(en)
|
2011-07-14 |
2013-01-17 |
R.E.D. Laboratories N.V../ S.A. |
Methods and compositions for evaluating and/or treating chronic immune diseases
|
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
|
CA2843388A1
(en)
|
2011-07-27 |
2013-01-31 |
Max International, Llc |
Compositions comprising sugar-cysteine products
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
RU2613322C2
(ru)
|
2011-08-30 |
2017-03-15 |
Академис Медис Сентрум |
Способ профилактики и/или лечения инсулинорезистентности
|
|
WO2013037068A1
(en)
|
2011-09-14 |
2013-03-21 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
|
WO2013066369A2
(en)
|
2011-10-03 |
2013-05-10 |
The Regents Of The University Of Michigan |
Methods for detecting graft-versus-host disease
|
|
US20130121968A1
(en)
|
2011-10-03 |
2013-05-16 |
Atossa Genetics, Inc. |
Methods of combining metagenome and the metatranscriptome in multiplex profiles
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
EP2750682B1
(en)
|
2011-10-11 |
2016-05-18 |
Achim Biotherapeutics AB |
Composition comprising anaerobically cultivated human intestinal microbiota
|
|
EP3569690B1
(en)
|
2011-12-01 |
2024-08-28 |
The University of Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
GB201201766D0
(en)
|
2012-02-01 |
2012-03-14 |
Imp Innovations Ltd |
Method
|
|
US20150125883A1
(en)
|
2012-04-30 |
2015-05-07 |
Washington University |
Method of isolating and characterizing microorganisms that are targets of host immune responses
|
|
EP3686284A1
(en)
|
2012-05-18 |
2020-07-29 |
Genome Research Limited |
Methods and groups
|
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
EP2854850B1
(en)
|
2012-05-25 |
2021-05-26 |
Sloan Kettering Institute For Cancer Research |
Compositions for treating or preventing radiation disease and gi syndrome
|
|
EP2684469A1
(en)
|
2012-07-13 |
2014-01-15 |
Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO |
Methods for strengthening and assessment of the natural defence of the colon against C. difficile overgrowth
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
DK3628161T3
(da)
|
2012-11-23 |
2023-05-30 |
Seres Therapeutics Inc |
Synergistiske bakterielle sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf
|
|
AU2014212004B2
(en)
|
2013-02-04 |
2018-09-20 |
Société des Produits Nestlé S.A. |
Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
|
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
|
WO2014153194A2
(en)
|
2013-03-14 |
2014-09-25 |
Seres Health, Inc. |
Methods for pathogen detection and enrichment from materials and compositions
|
|
EP2967077A4
(en)
*
|
2013-03-15 |
2016-09-14 |
Seres Therapeutics Inc |
NETWORK-BASED MICROBIAL COMPOSITIONS AND METHOD
|
|
CN105142654B
(zh)
|
2013-05-03 |
2020-04-10 |
雀巢产品有限公司 |
肠小型生物群中的毛螺菌科和与体重的关联
|
|
KR101913016B1
(ko)
*
|
2013-08-05 |
2018-10-29 |
다이이찌 산쿄 가부시키가이샤 |
간장해 형태의 검사방법
|
|
WO2015018307A1
(en)
|
2013-08-06 |
2015-02-12 |
Bgi Shenzhen Co., Limited |
Biomarkers for colorectal cancer
|
|
KR102611070B1
(ko)
|
2013-11-25 |
2023-12-07 |
세레스 테라퓨틱스, 인코포레이티드 |
상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
ES2938361T3
(es)
|
2015-11-24 |
2023-04-10 |
Seres Therapeutics Inc |
Composiciones de bacterias diseñadas
|
|
BR112018012022A2
(pt)
*
|
2015-12-14 |
2018-12-04 |
Metabogen Ab |
?composição, e, método para tratamento ou redução do risco de colestase intra-hepática?
|
|
CA3016911A1
(en)
|
2016-03-14 |
2017-09-21 |
Holobiome, Inc. |
Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
|
|
MX2020001774A
(es)
|
2017-08-14 |
2020-09-09 |
Seres Therapeutics Inc |
Composiciones y métodos para tratar enfermedad colestásica.
|
|
EP3691664A4
(en)
|
2017-10-03 |
2021-08-04 |
Seres Therapeutics, Inc. |
HANDLING OF TRYPTAMINE METABOLISM
|
|
BR112020008552A2
(pt)
|
2017-10-30 |
2020-12-29 |
Seres Therapeutics, Inc. |
métodos e composições para tratamento de resistência a antibiótico
|
|
US20210121505A1
(en)
|
2018-03-29 |
2021-04-29 |
Seres Therapeutics, Inc. |
Compositions and methods for treating inflammatory bowel diseases
|
|
MX2020012602A
(es)
|
2018-05-24 |
2021-03-31 |
Seres Therapeutics Inc |
Composiciones bacterianas dise?adas y usos de las mismas.
|